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Abstract
Accumulating data indicate that the ubiquitin-proteasome system controls apoptosis by regulating
the level and the function of key regulatory proteins. In the present study, we identified Trim17, a
member of the TRIM/RBCC protein family, as one of the critical E3 ubiquitin-ligases involved in
the control of neuronal apoptosis upstream of mitochondria. We show that expression of Trim17 is
increased both at the mRNA and protein level in several in vitro models of transcription-dependent
neuronal apoptosis. Expression of Trim17 is controlled by the PI3K/Akt/GSK3 pathway in
cerebellar granule neurons (CGN). Moreover, the Trim17 protein is expressed in vivo, in apoptotic
neurons that naturally die during postnatal cerebellar development. Overexpression of active
Trim17 in primary CGN was sufficient to induce the intrinsic pathway of apoptosis in survival
conditions. This proapoptotic effect was abolished in Bax−/− neurons and depended on the E3
activity of Trim17 conferred by its RING domain. Furthermore, knock-down of endogenous
Trim17 and overexpression of dominant-negative mutants of Trim17 blocked trophic factor
withdrawal-induced apoptosis both in CGN and in sympathetic neurons. Collectively, our data are
the first to assign a cellular function to Trim17 by showing that its E3 activity is both necessary
and sufficient for the initiation of neuronal apoptosis.
Keywords
apoptosis; neurons; ubiquitin-proteasome system; E3 ubiquitin-ligase; Trim17; cerebellum
Introduction
In the nervous system, apoptosis plays an essential role during development. Accumulating
data also suggest that aberrant apoptosis may be involved in some pathological conditions
such as stroke and neurodegenerative diseases.1 In neurons, caspases are predominantly
activated through the intrinsic pathway, that involves cytochrome c release from
mitochondria and formation of the apoptosome, which results in activation of caspase 9 and
subsequent activation of downstream caspases.2 The proteins of the Bcl-2 family, that
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tcomprises both anti-apoptotic (Bcl-2, Bcl-xL, Mcl-1…) and pro-apoptotic members (Bax,
Bak…), are key regulators that control the release of cytochrome c and other apoptogenic
factors from mitochondria.3 Some signalling pathways regulating the survival/death fate of
neurons are now well characterized. For example, the Phosphatidyl Inositol-3-OH Kinase
(PI3K)/Akt cascade plays an essential role in the survival of many types of neurons,1
notably by inhibiting Glycogen Synthase Kinase 3 (GSK3).4 Little is known, however,
regarding the molecular mechanisms that link these signalling pathways to the mitochondrial
apoptotic machinery. Increasing data suggest that the ubiquitin-proteasome system (UPS)
may constitute one of these links, by regulating the level or the function of key regulatory
proteins.5,6
The UPS is the main non-lysosomal proteolytic system for degrading cellular proteins.7 To
be recognized by the proteasome, specific Lys residues in the substrate protein are
covalently conjugated to poly-ubiquitin chains in a process that involves the sequential
action of E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme) and E3
(ubiquitin protein ligase) enzymes. The E3s confer a high degree of selectivity to this
process by recognizing the target proteins.8 Proteasome inhibitors have been shown to
prevent apoptosis in several neuronal types.9,10 This suggests that the “road-blockers” of the
apoptotic pathways have to be eliminated by the UPS for the death process to be initiated in
neurons.
In a previous study,11 we analyzed the gene expression profile of cerebellar granule neurons
(CGN) during early apoptosis. CGN require serum and depolarizing levels of extracellular
KCl ([KCl]o = 25 mM) for their survival in vitro and die via the mitochondrial apoptotic
pathway when deprived of this trophic support.12 CGN apoptosis is dependent on both
proteasome activity9 and macromolecular synthesis.12 Among genes highly upregulated in
apoptotic versus control CGN, we found Trim17, also known as terf (testis RING finger
protein13). Trim17 was first isolated from a rat testis cDNA library13 but it is also expressed
in spleen and thymus and to a lesser extent in liver, kidney and brain.14 The protein Trim17
is a member of the TRIM family that is defined by the presence of the tripartite motif (or
RBCC), comprising a RING finger domain, one or two B-boxes and an associated coiled-
coil domain.15,16 The tripartite motif can be followed by a variety of C-terminal domains. In
Trim17, as in the majority of TRIM proteins,15 it is a PRY-SPRY domain. Recent
experimental evidence suggests that the TRIM family represents one of the largest classes of
single-protein, RING-containing, E3 ubiquitin ligases.17 Consistently, TRIM17 has been
shown to have an E3 activity.14 However, no cellular function has been ascribed to this
protein up to now.
In the present study, we have examined the role of Trim17 in neuronal apoptosis. We have
shown that Trim17 is induced in several models of neuronal apoptosis, both in vitro and in
vivo. Moreover, our overexpression and silencing data indicate that Trim17 is necessary and
sufficient for inducing the Bax-dependent intrinsic pathway of neuronal apoptosis and that
its pro-apoptotic effect depends on its E3 activity. Taken together, our results indicate for
the first time that Trim17 is a critical E3 ubiquitin-ligase involved in neuronal apoptosis.
Results
Induction of Trim17 mRNA during initiation of neuronal apoptosis
In order to identify genes whose expression is required for neuronal apoptosis, we used
DNA microarrays and we compared gene expression in CGN incubated in serum-free
medium containing either 25 mM KCl (K25, survival) or 5 mM KCl (K5, apoptosis) for 4 h.
11 Trim17 was one of the most highly upregulated genes after KCl deprivation with a K5/
K25 expression ratio of 8.94 ± 1.59 (average ± SD of three independent experiments). Real-
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ttime RT-PCR analysis confirmed this induction with a K5/K25 mRNA ratio of 17.55 ± 4.26.
The peak of Trim17 mRNA level, 4 h after KCl deprivation (Figure 1a), precedes the
appearance of the first hallmarks of apoptosis.11
To determine whether the expression of Trim17 was directly related to apoptosis, the Trim17
mRNA levels were assessed in further conditions (Figure 1b). Inhibition of PI3K has been
shown to induce transcription–dependent apoptosis in CGN,18 as confirmed in our culture
conditions (Figure 1c). Consistently, in CGN incubated with the PI3K inhibitor LY-294002
in K25 medium, Trim17 mRNA was increased to the same extent as in KCl-deprived CGN
(Figure 1b). Conversely, inhibition of GSK3 by the very specific inhibitor AR-A01441819
completely prevented CGN death (Figure 1d), confirming previous results with other GSK3
inhibitors.20,21 In KCl-deprived CGN protected by AR-A014418, induction of Trim17
mRNA was completely abolished (Figure 1b). Collectively, these results demonstrate that
Trim17 induction is associated with neuronal apoptosis independently of the [KCl]o, and that
expression of Trim17 is controlled by the PI3K/Akt/GSK3 pathway in CGN.
The mRNA level of Trim17 was also significantly increased in two other models of
transcription-dependent neuronal apoptosis22,23: in rat sympathetic neurons from the
superior cervical ganglion (SCG) after NGF withdrawal, and in motoneurons from mouse
spinal cord maintained in the absence of neurotrophic factors (Table 1). Although the
induction of Trim17 was lower in these models, possibly due to slower apoptotic kinetics, it
was reproducible and significant.
To examine whether Trim17 may be part of an adaptive response to stress, we studied its
expression during CGN apoptosis induced by low concentrations (30-50 μM) of glutamate.
This model of neuronal death is apoptotic (supplemental Figure S1) but it is transcription-
independent,24 as confirmed by our data (Figure 1e). However, the level of Trim17 mRNA
did not increase after treatment with glutamate (Table 1). Overall, these observations
suggest that Trim17 is specifically expressed in transcription-dependent apoptosis, induced
by trophic factor deprivation, but not during transcription-independent apoptosis.
Expression of the Trim17 protein during in vitro and in vivo neuronal apoptosis
To study the expression of Trim17 at the protein level, we generated an anti-peptide
polyclonal antibody that we purified by affinity. In Western blots, this antibody recognizes
overexpressed or recombinant Trim17 very well but it is not sensitive enough to efficiently
detect the endogenous protein. Nevertheless, this antibody generates a weak signal in
immunofluorescence that decreases in CGN transduced with a short hairpin RNA that
specifically targets Trim17 mRNA (ShRNA Trim17, Figure 8a) and in SCG neurons
microinjected with two different small interfering RNAs (siRNAs) against Trim17 (Figure
8d), demonstrating the specificity of the immunodetection. We first used this antibody to
determine whether Trim17 is also induced at the protein level during neuronal apoptosis.
Using confocal microscopy, a faint, but higher Trim17 immunostaining could be detected in
KCl-deprived CGN compared to CGN maintained in K25 medium (Figure 2a). A similar
increase of the protein level of Trim17 was also detected in SCG neurons after NGF
withdrawal (Figure 2b).
To investigate whether Trim17 is also expressed in vivo, we next performed
immunohistochemistry analyses of mouse cerebellum sections. Trim17 immunoreactivity
was detected in evenly scattered cells in the external granular layer (EGL) but more
predominantly in the developing internal granular layer (IGL), seven days after birth (P7,
Figure 3a, left panel). It is well documented that a peak of naturally occurring neuronal
death takes place in these areas at this stage. This death has been demonstrated to be
apoptotic25 as confirmed by our immunodetection of active caspase 3 (Figure 3a, right
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tpanel). When estimated at different stages of post-natal cerebellar development, Trim17
expression and caspase 3 activation both peaked at P7 (Figure 3b). Trim17 and active
caspase 3 could be detected in the same place on adjacent sections (Figure 3c), suggesting
that they are present in the same neurons. Taken together, these observations suggest a
possible role of Trim17 in developmental neuronal death in vivo.
E3 ubiquitin-ligase activity of Trim17 and its mutants
As human TRIM17 has been shown to auto-ubiquitinate in vitro14, we tested murine Trim17
in similar ubiquitination assays. Immunoblotting shows a single band with increased
apparent size after incubation with the E2 enzyme Ube2e1 (Figure 4a, Figure S2b), whereas
a ladder of higher molecular mass species could be detected with Ube2d2 and with Ube2d3
(Figure 4a & c, Figure S2a). These bands likely correspond to mono-ubiquitinated and poly-
ubiquitinated forms of Trim17, respectively, as they could be detected by both anti-Trim17
and anti-ubiquitin antibodies. As the reaction mix was free of E3 except Trim17, these
results indicate that mouse Trim17 is capable of auto-ubiquitination. In contrast to human
TRIM17 which has been shown to preferentially cooperate with Ube2e1 to induce poly-
ubiquitination,14 mouse Trim17 also acts efficiently with Ube2d2 and Ube2d3 and generates
mostly mono-ubiquitination with Ube2e1 (Figure 4a). These discrepancies may result from
differences between human and mouse proteins or between experimental conditions.
In order to study the cellular function of Trim17, we constructed several RING domain
mutants of Trim17 (Figure 4b). The RING is a Cys-rich zinc-binding motif that has been
shown to confer E3 ubiquitin ligase activity to many proteins, including most TRIMs.17
Therefore, we first created a deletion (ΔRING) and a point mutation (C16A), in which one
of the Cys residues (C16) responsible for coordination of zinc was replaced by Ala (Figure
4b). Consistently, GST-Trim17(ΔRING) and GST-Trim17(C16A) were incapable of auto-
ubiquitination in vitro, regardless of the E2 enzyme used (Figure 4c, Figure S2). Human
TRIM17 has been shown to be degraded by the proteasome when overexpressed in cell
lines.14 As mouse Trim17(ΔRING) initially seemed to be more stable than wild type (WT)
Trim17 (data not shown), we hypothesized that Trim17 might be ubiquitinated on its RING
domain. In an attempt to create a more stable but still active mutant of Trim17, all the Lys
residues present in the RING were replaced by Arg residues (Figure 4b). If Trim17 is
actually ubiquitinated on these Lys, this K2R mutant might be less degraded by the
proteasome in cells. However, it should maintain the structure of its RING intact. Pulse-
chase experiments, however, showed that the half-life of Trim17(K2R) is not significantly
different from that of WT Trim17 and of the other Trim17 mutants (Figure S3).
Nevertheless, in vitro ubiquitination assays showed that Trim17-K2R is capable of auto-
ubiquitination (Figure 4c, Figure S2a). These data thus indicate that Trim17(WT) and
Trim17(K2R) have an E3 ubiquitin-ligase activity whereas Trim17(ΔRING) and
Trim17(C16A) are inactive mutants.
Expression of Trim17 is sufficient to trigger the mitochondrial apoptotic pathway in CGN
To evaluate the effect of Trim17 on neuronal survival/death fate, CGN were transfected with
mouse Trim17 fused to green-fluorescent protein (GFP). Expression of Trim17-GFP
coincided with chromatin condensation and caspase 3 activation in a large proportion of
transfected neurons (Figure 5b). In healthy neurons, the immunostaining pattern for
cytochrome c was intense and punctate, indicating a mitochondrial localization, whereas it
disappeared in dying neurons expressing Trim17-GFP (Figure 5b). It is likely that this
absence of immunoreactivity reflected degradation of cytochrome c following its release
from mitochondria, as described elsewhere.26 In contrast, neither cytochrome c release nor
activation of caspase 3 was detectable in most CGN transfected with GFP alone or with the
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tinactive mutant Trim17(ΔRING)-GFP (Figure 5a & c). These observations therefore suggest
that Trim17 expression can trigger the intrinsic pathway of apoptosis in CGN.
To further examine this point, Trim17-GFP was transfected into CGN obtained from Bax-
deficient mice and their wild type littermates. Neuronal death has been previously shown to
be completely prevented in Bax−/− CGN maintained in low KCl level for several days.27
Similarly, Trim17 did not induce apoptosis in Bax−/− CGN (Figure 6a). Indeed, both WT
Trim17-GFP and the active mutant Trim17(K2R)-GFP had a strong pro-apoptotic effect in
Bax+/+ and Bax+/− CGN compared to GFP used as a negative control. In contrast, apoptosis
was negligible in Bax−/− neurons transfected with the three constructs (Figure 6b).
Interestingly, heterozygous Bax+/− CGN died to the same extent as wild type Bax+/+ CGN
upon transfection with Trim17-GFP (Figure 6b), as upon KCl deprivation.27 As Bax is
necessary for cytochrome c release, these results demonstrate that Trim17 expression is
sufficient to trigger the intrinsic pathway of apoptosis in CGN.
The E3 ubiquitin-ligase activity of Trim17 is required for neuronal apoptosis
To better assess the role of Trim17 in neuronal apoptosis, the effect of its different mutants
was thoroughly quantified in control and apoptotic neurons. First, CGN were transfected
with either Trim17-GFP variants or GFP for 16 h, and were maintained in initial culture
medium (Ctrl) or switched to apoptotic K5 medium for an additional 8 h period. Then, the
percentage of transfected neurons undergoing apoptosis was determined (Figure 7a).
Compared to GFP, expression of the active forms of Trim17-GFP (WT and K2R) was
sufficient to induce CGN apoptosis in survival conditions, and to aggravate apoptosis after
KCl deprivation. In contrast, the inactive mutants Trim17(ΔRING)-GFP and
Trim17(C16A)-GFP did not trigger significant apoptosis in control conditions. More
importantly, expression of these mutants completely protected CGN from KCl deprivation-
induced apoptosis (Figure 7a). This effect was associated with inhibition of cytochrome c
release and caspase 3 activation (Figure 7b).
This strong protection was reproduced in sympathetic SCG neurons deprived of NGF
(Figure 7c). In these experiments, expression vectors encoding the different forms of
untagged Trim17 were microinjected together with a fluorescent marker. Then, neurons
were deprived of NGF and the number of viable injected neurons was determined at this
time (0) and subsequently, every 24 h. After NGF withdrawal, SCG neurons injected with
the plasmids expressing WT Trim17 and Trim17(K2R) showed a similar time course of
neuronal death compared to neurons injected with the empty vector pCI. In contrast, SCG
neurons microinjected with expression vectors encoding Trim17(ΔRING) and
Trim17(C16A) showed strongly increased survival after NGF deprivation. This protection
was close to that observed in neurons cultured in the presence of NGF (Figure 7c) and
similar to the effect of Bcl-2 or dominant negative c-Jun in the same type of microinjection
assay.28
Taken together these results show that the pro-apoptotic effect of Trim17 depends on the E3
activity conferred by its RING domain. More importantly, mutations of the RING generally
induce a dominant negative effect.8 Therefore, the protective effect of the ΔRING and C16A
mutants strongly suggests that the E3 activity of Trim17 is necessary for neuronal apoptosis
both in CGN and SCG neurons.
Knockdown of Trim17 expression in primary neurons prevents apoptosis
In order to confirm the role of Trim17 in neuronal apoptosis, we knocked down the
expression of endogenous Trim17 in CGN by using lentiviruses expressing ShRNAs. One
sequence (ShRNA Trim17) that specifically targets the Trim17 mRNA was particularly
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tefficient at decreasing the protein level of Trim17 (Figure 8a). Most importantly, this down-
regulation was associated with almost complete protection of CGN against KCl deprivation–
induced apoptosis. Indeed, nuclear condensation and caspase 3 activation were strongly
decreased in CGN transduced with ShRNA Trim17 (Figure 8a-c). In contrast, the control
ShRNA, that did not significantly affect the protein level of Trim17 compared to non-
transduced neurons (Figure 8a), had no protective effect. It was rather toxic in its own right
(Figure 8a, b).
Similar results were obtained in SCG neurons microinjected with a non-targeting control
siRNA and two siRNAs targeting different specific sequences in Trim17 (siRNA#1 and #2).
Whereas the control siRNA did not affect the level of Trim17 protein significantly, the
immunostaining of Trim17 almost completely disappeared in a majority of sympathetic
neurons microinjected with siRNA#1 and was reduced to a lower, but significant, extent in
most neurons injected with siRNA#2 (Figure 8d, Table 2). Consistently, survival was
significantly increased in SCG neurons microinjected with siRNA#1, and slightly improved
with siRNA#2, compared to neurons injected with the control siRNA, after NGF deprivation
(Figure 8e). This suggests that only a profound reduction of the Trim17 protein level can
afford protection against death.
To check that the absence of Trim17 is actually responsible for the protection observed after
RNA interference, we transfected a form of Trim17 in which the sequence targeted by
ShRNA Trim17 has been mutated in order to be resistant to ShRNA-mediated degradation.
Consistently, we could express this form of Trim17 fused to the fluorescent protein mCherry
(Trim17-res-mCherry) in CGN previously transduced with ShRNA Trim17 (Figure 9). More
importantly, expression of this form of Trim17 restored the ability of neurons to undergo
apoptosis after KCl deprivation whereas transfection with mCherry alone did not (Figure 9).
Taken together, these silencing data further confirm that Trim17 expression is necessary for
the initiation of neuronal apoptosis.
Discussion
Accumulating evidence indicates that the UPS is involved in the control of apoptosis.5,6
However, only a few proteins whose degradation by the proteasome is necessary for
apoptosis have been identified so far, and the crucial E3 ubiquitin ligases responsible for
their recognition remain mostly unknown. In the present study, we have identified Trim17 as
a critical E3 ubiquitin ligase whose expression is sufficient and necessary for triggering the
intrinsic pathway of apoptosis in different neuronal types. Indeed, transfection of CGN with
the active forms of Trim17 was sufficient, in itself, to trigger apoptosis in survival
conditions. In contrast, two inactive mutants did not induce apoptosis. Moreover, Trim17-
induced apoptosis was completely abrogated in Bax−/− CGN that are resistant to KCl
deprivation but are still sensitive to glutamate-induced cell death.27 Taken together, these
data show that the pro-apoptotic effect of Trim17 is not the toxic consequence of
transfection or accumulation of an exogenous protein prone to aggregation, but results from
the specific activation of the intrinsic apoptotic pathway. Importantly, the dominant negative
mutants of Trim17 blocked apoptosis both in KCl-deprived CGN and in NGF-deprived SCG
sympathetic neurons. Different constructs and different gene transfer methods were used in
the two models but gave the same results, underlying the robustness of this observation. This
strong protective effect indicates that the E3 activity of Trim17 is necessary for the initiation
of neuronal death. This was further confirmed by silencing experiments, using different
RNA interference tools, in which the reduction of Trim17 protein afforded a significant
protection of both CGN and SCG neurons after trophic factor withdrawal.
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data are the first to assign a cellular function to Trim17. They also establish a novel pathway
linking the PI3K/Akt/GSK3 cascade with the mitochondrial apoptotic machinery. In the past
years, extensive studies have demonstrated that depolarization-induced calcium entry and
activation of neurotrophin receptors can trigger the PI3K/Akt pathway which plays a crucial
role in neuronal survival,1 notably by inhibiting the pro-apoptotic kinase GSK3β.4
Nevertheless, little is known about the mechanisms that control the apoptotic machinery
downstream of Akt or GSK3 in neurons. In CGN, Akt has been shown to phosphorylate the
pro-apoptotic BH3-only protein Bad29, as well as members of the Forkhead family of
transcription factors, which suppresses the transactivation of death-promoting genes such as
Fas ligand and bim.30,31 Although the BH3-only protein Bim clearly plays an important
role,32 analysis of neurons from different KO mice has cast a doubt on the role of Bad and
Fas ligand in neuronal apoptosis.33 More recently, phosphorylation of Bax by GSK3β has
been shown to promote the translocation of Bax to mitochondria and the induction of
apoptosis in CGN.34 By demonstrating that Trim17 plays a decisive role in the initiation of
neuronal death upstream of Bax and that its expression is controlled by the PI3K/Akt/GSK3
cascade, we have now identified a novel link between these signalling pathways and the
mitochondria.
Our immunohistochemistry data indicate that Trim17 protein is expressed in vivo, in the
cerebellum, during post-natal development. Its peak of expression coincides with the peak of
naturally occurring neuronal apoptosis that takes place at P7. It is thus plausible that the role
of Trim17, that we have identified in vitro, is also of crucial importance for apoptosis in
vivo. Moreover, the fact that Trim17 is highly expressed in organs with a high rate of
constitutive apoptosis such as testis, spleen and thymus,14 is consistent with a possible role
of Trim17 in the regulation of apoptosis in other cell types.
In this study, we present evidence that Trim17 plays an essential role in the triggering of
neuronal apoptosis via its E3 activity. Our work is therefore a new contribution to the
picture of apoptosis regulation by the UPS and provides a new starting point to elucidate
these mechanisms. A simple hypothesis would be that, following an apoptotic stimulus, de
novo expressed Trim17 ubiquitinates and targets key anti-apoptotic proteins to the
proteasome. Identification of ubiquitination substrates of Trim17 is thus under progress.
However, ubiquitination mediated by Trim17 may have other consequences than
proteasomal degradation: change of localization, activation or neutralization, change in
expression. Moreover, TRIM proteins often associate in homo/hetero-oligomers through
their coiled-coil domains to form large protein complexes.15 For example, TRIM17 has been
shown to interact with, and to be stabilized by TRIM44.14 It is thus plausible that the
activity of Trim17 may be influenced or may influence other members of the TRIM family.
This will have to be taken into consideration for the identification and validation of Trim17
substrates.
Materials and Methods
Primary cultures of neurons
Bax+/− mice were generated by the laboratory of Dr S. Korsmeyer35 and were purchased
from The Jackson Laboratory (strain B6.129X1-Baxtm1Sjk/J). Bax deficient mice (Bax−/−)
were obtained by mating of heterozygotes. The offspring were genotyped by PCR according
to the protocol provided by The Jackson Laboratory, with genomic DNA prepared from tails
using the REDExtract-N-Amp™ Tissue PCR Kit (Sigma). Common C57Bl/6 mice (from
Charles River Laboratories) were bred in house.
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tCGN cultures were prepared from 7-day-old murine pups as described previously11 with
slight modifications. Briefly, freshly dissected cerebella were incubated for 10 min at 37°C
with 0.25 mg/ml trypsin and cells were dissociated in HBSS -Ca2+ -Mg2+ in the presence of
0.5 mg/ml trypsin inhibitor and 0.1 mg/ml DNaseI by several steps of mechanical disruption
with a flame-polished Pasteur pipette. The resulting cell suspension was filtered through a
40 μm cell strainer (BD Falcon) and centrifuged at 200 × g for 10 min. Cells were gently
resuspended in K25+S medium (Basal Medium Eagle [BME, GIBCO® Invitrogen.]
supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 10 mM HEPES, penicillin-
streptomycin 100 IU/ml-100 μg/ml and 20 mM KCl to achieve a final concentration of 25
mM), counted and seeded at a density of 250 000 cells/cm2 in culture dishes previously
coated with 20 μg/ml poly-D-lysine (Becton Dickinson Biosciences). For
immunofluorescence and transfection experiments, CGN were cultured on glass coverslips
coated with 16.67 μg/ml laminin (Sigma) and 33.3 μg/ml poly-D-lysine. CGN were cultured
at 37°C in a humidified incubator with 5% CO2/95% air for 6 days. To prevent proliferation
of remaining nonneuronal cells, the anti-mitotic cytosine β-D-arabinofuranoside (10 μM Ara-
C) was added to the culture medium 24 h after plating. At 6 days in vitro (DIV) granule
neurons represented more than 98% of cultured cells (data not shown).
Sympathetic neurons were isolated from the superior cervical ganglia (SCG) of one-day-old
Sprague Dawley rats and cultured as previously described36. The ganglia were dissociated
by incubation for 30 min at 37°C in 0.025% trypsin and then for 30 min at 37°C in 0.1%
collagenase, followed by trituration through the tip of a Gilson P1000. After centrifugation
(at 200 × g for 10 min), neurons were gently resuspended in SCG medium (DMEM
containing 4.5 g/l glucose and 110 mg/l pyruvate [Sigma] supplemented with 10 % fetal calf
serum, penicillin/streptomycin and 2 mM L-glutamine) containing 50 ng/ml 2.5S NGF
(Cedarlane) to sustain survival, and fluorodeoxyuridine (20 μM) and uridine (20 μM) to
prevent the proliferation of non-neuronal cells. Typically 6 400–8 000 neurons were plated
on 13 mm diameter glass coverslips coated with poly-L-lysine and laminin. Fresh medium
was added after 1, 2, 4 and 6 days in culture. Cells were used for experiments at DIV 5–7. In
NGF-withdrawal experiments, neurons were rinsed twice with medium (without NGF) and
were re-fed with medium containing anti-NGF antibody (100 ng/ml).
Motoneuron cultures were prepared from E12.5 ventral mouse spinal cords as described
previously37 with slight modifications. In brief, cells were dissociated after trypsin
treatment. The largest cells were isolated by centrifugation on a 5.2% Optiprep density
gradient and were subsequently centrifuged through a bovine serum albumin cushion.
Motoneurons were resuspended in Neurobasal medium supplemented with 2% horse serum,
25 μM L-glutamate, 25 μM β-mercaptoethanol, 0.5 mM L-glutamine and 2% B-27
supplement (GIBCO® Invitrogen). Motoneurons were plated on plates previously coated
with polyornithine/laminin, in the presence or not of a cocktail of neurotrophic factors
consisting of 1 ng/ml human brain-derived neurotrophic factor (BDNF), 100 pg/ml rat glial
cell line-derived neurotrophic factor (GDNF) and 10 ng/ml ciliary neurotrophic factor
(CNTF), added at the time of seeding.
RNA preparation and real time quantitative RT-PCR
Total RNA was extracted using the RNAqueous® kit (Ambion) and treated with DNase I
from the DNA-free™ kit (Ambion) according to manufacturer’s instructions. RNAs were
used to perform a two-step reverse-transcription polymerase chain reaction (RT-PCR).
Briefly, 1 μg of total RNA was reverse transcribed using 200 U M-MLV reverse
transcriptase (Invitrogen) in the presence of 2.5 μM N6 random primers and 0.5 mM dNTP.
The equivalent of 6 ng of resulting cDNA was used as a template for real time PCR using a
Mx3000P thermocycler (Agilent) with a home-made SYBR Green QPCR master mix.38 The
sequences of the primers used were the following: for mouse Trim17: 5′
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tAGGGAGTATAAGCTCAAGTTGGA 3′ and 5′ CCTGCCACTCAGTTAAGGTCT 3′; for
mouse cJun: 5′ GCCCTCAACGCCTCGTT 3′ and 5′ GCCAGGTTCAAGGTCATGCT 3′;
for rat Trim17: 5′ CTACCCAATTCCATTCCAGTCACAC 3′ and 5′
CAAGCAGAAGAACGGCAGCAG 3′; for rat cJun: 5′
GTGAAGTGACCGACTGTTCTATGAC 3′ and 5′
AATCTTAGGGTTACTGTAGCCGTAGG 3′. PCR reactions were performed in 10 μl in
the presence of 150-300 nM primers. Thermal cycling parameters were 10 min at 95°C,
followed by 40 cycles of 95°C for 30 s, 64°C for 30 s and 72°C for 30 s. Data were analyzed
and relative amounts of specifically amplified cDNA were calculated with MxPro software
(Agilent). The mouse and the rat β-2 Microglobulin amplicons were used as references
(mouse primers: 5′ TATGCTATCCAGAAAACCCCTCAA 3′ and 5′
GTATGTTCGGCTTCCCATTCTC 3′; rat primers: 5′
TCTTTCTGGTGCTTGTCTCTCTGG 3′ and 5′ CATCGGTCTCGGTGGGTGTG 3′).
KCl deprivation of CGN cultures and survival assay
At DIV 6, CGN cultured in 24 well plates were washed once and then incubated for
indicated times in serum-free BME supplemented with L-Gln, HEPES, antibiotics and 1 μM
of the NMDA antagonist (+)-MK-801, and containing either 25 mM KCl (K25 medium) or
5 mM KCl (K5 medium) to respectively sustain survival or induce apoptosis. When
indicated, different drugs were added to K25 and K5 media. LY-294002 and AR-A014418
(GSK3 inhibitor VIII) were from Calbiochem and other chemicals were from Sigma-
Aldrich. In the case of glutamate treatment, (+)-MK-801 was omitted. Then, neuronal
survival was assessed in triplicates by the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazoliumbromide) assay. Briefly, culture medium was replaced by K25 medium
containing 0.5 mg/ml MTT and neurons were returned to the incubator for 2 h. Medium was
removed and blue formazan produced by living cells was dissolved in DMSO. The optical
density of blue formazan was estimated at 595 nm.
cDNA cloning of Trim17 and generation of specific antibodies
Single-stranded random-primed cDNA prepared from mouse apoptotic CGN was used as a
template for PCR amplification of Trim17 cDNA using the following primers 5′
GGAATTCTGAGCCATGGATGCGGTGGAGCTTG 3′ and 5′
GCTCTAGACTATCCCTTCACCCACATGGTC 3′. The PCR product was cloned between
the EcoRI and XbaI sites of pCI (Promega) to create pCI-Trim17. In order to produce
recombinant Trim17 in Escherichia coli, an 8-histidine tag was first added to the N-terminus
of Trim17 by annealing oligonucleotides 5′
CTAGCCATGGCGCATCATCACCATCATCACCATCACGGCGCGCCG 3′ and 5′
AATTCGGCGCGCCGTGATGGTGATGATGGTGATGATGCGCCATGG 3′ and cloning
them between the NheI and EcoR1 sites of pCI-Trim17 to create pCI-His(8)-Trim17. An
EcoR1-SalI fragment was sub-cloned from this plasmid into pET-23d(+) plasmid (Novagen)
to create pET-23d-His(8)-Trim17.
In order to raise a polyclonal antibody against recombinant full-length Trim17, pET-23d-
His(8)-Trim17 was transformed in Rosetta (DE3) Escherichia coli. Protein expression was
induced by 400 μM of isopropyl β-D-thiogalactopyranoside (IPTG) and was carried out at
25°C for 4 h. Then, bacteria were lysed in Bugbuster HT (Novagen). Inclusion bodies
containing Trim17 were dissolved in Laemmli buffer and Trim17 was separated by
preparative SDS PAGE. The band containing Trim17 was excised and electro-eluted in 500
μl buffer (Tris 25 mM, Gly 192 mM, SDS 0.025%). About 10 μg of protein was injected to
immunize rabbits. Another rabbit polyclonal antibody was generated by Eurogentec against
two peptides from Trim17: H2N-RQRRYLSPPPEGSAPY-CONH2 (peptide 339) and H2N-
KSFQEDVMPDPSSAC-CONH2 (peptide 340) following the double X program
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peptide 340 immobilized on HiTrap NHS-activated columns (GE Healthcare) according to
the manufacturer’s instructions.
Immunofluorescence
After apoptosis induction, or one day after transfection, CGN were fixed with 4%
paraformaldehyde for 20 min at room temperature. They were then washed with PBS and
permeabilised with 0.5% Triton X-100 in PBS at room temperature for 5 min. After
blocking with PBS + 5% normal goat serum for 30 min at room temperature, coverslips
were incubated overnight with primary antibodies diluted in PBS + 5% normal goat serum at
4°C: mouse monoclonal antibody against the native form of cytochrome c (1:20; BD
Pharmingen #556432), rabbit polyclonal antibody against the cleaved form (Asp175) of
caspase 3 (1:500; Cell Signaling Technology #9661) or purified anti-peptide antibody
against Trim17 (1:100). Neurons were then washed twice in PBS and developed with Alexa
Fluor® 488 and Alexa Fluor® 594-labeled goat anti-mouse and goat anti-rabbit antibodies
(Molecular Probes, dilution 1:1000 in PBS + 5% normal goat serum). In the last wash, 1 μg/
ml of Hoechst 33258 (Sigma) was added to the cells for 10 min at room temperature.
Coverslips were set in Mowiol (polyvinyl alcohol 4-88, Fluka) on glass slides and analyzed
for fluorescence. SCG neurons were treated as CGN, except that blocking was performed
using 50% normal goat serum and 1% bovine serum albumin (BSA) in PBS and the anti-
Trim17 antibody (diluted in 10% normal goat serum and 1% BSA in PBS) was incubated for
90 min at room temperature. Two secondary antibodies (Jackson Immunoresearch Inc.) were
used: a fluorescein-conjugated goat anti-rabbit antibody (1:500) to detect Trim17 and a
rhodamine-conjugated donkey anti-guinea pig antibody (1:100) to detect microinjected
neurons. The nuclei of SCG neurons were stained with DAPI dye in Antifade (Dako) and
the neurons mounted on glass slides.
Immunohistochemistry
Mouse brains from different stages of post-natal development were isolated and fixed in 4%
paraformaldehyde in PBS overnight at 4°C, dehydrated and embedded in paraffin. Sagittal
sections (4 μm thick) were cut, mounted on slides, incubated in citrate buffer for 30 min at
99°C for antigen retrieval, incubated in 1% H2O2 for 10 min at room temperature to inhibit
endogenous peroxidases, blocked with 20% normal horse serum in TBS for 30 min and with
avidin and biotin for 15 min (Blocking kit, Vector laboratories), with three washes in TBS
plus 0.1% Tween-20 (TBST) after each step. Then, slides were incubated for 2 h at room
temperature in a 1:50 dilution of purified anti-peptide Trim17 antibody or 1:100 cleaved
caspase 3 antibody in TBS plus 5% horse serum. After TBST washes, the slides were
incubated with biotinylated goat anti-rabbit secondary antibody (Vector laboratories) in TBS
plus 5% horse serum, for 45 min at room temperature. After TBST washes, the
immunolabeling was revealed using the Vectastain® ABC kit and DAB (Vector
laboratories) according to the manufacturer’s instructions. Following dehydration, slides
were mounted in Vectamount medium (Vector laboratories) and analyzed by conventional
microscopy.
Site-directed mutagenesis of Trim17
The pCI-Trim17(C16A) mutant was obtained by site-directed mutagenesis of pCI-Trim17,
using the QuikChange II XL kit (Stratagene), with the primers 5′
CAAGAGGAGGCCACAGCTTCCATCTGCCTTGACTAC 3′ and 5′
GTAGTCAAGGCAGATGGAAGCTGTGGCCTCCTCTTG 3′. pCI-Trim17(ΔRING) was
obtained by removing an EcoR1-StuI fragment from pCI-Trim17 and replacing it with an
EcoR1-StuI fragment (lacking the RING domain) cloned by PCR with primers 5′
TTAGAATTCTCCCCTCAGAGGAACCTGAGGC 3′ and 5′
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tCAGGGAGGCCTTGCTGTCCTG 3′, using pCI-Trim17 as template. The pCI-
Trim17(K2R) mutant, in which the eight lysine residues of the RING domain were replaced
by arginines, was obtained by recombinant PCR. Two overlapping fragments were amplified
using pCI-Trim17 as template, the first with primers 5′
CGAGAATTCTGAGCCATGGATGC 3′ and 5′
CCTCTGCCTCCTCCTCCCCCTTCGAACCCTCCCCCTCTCCCAGCTCATCTGGATGC
3′, the second with primers 5′
AGCTGGGAGAGGGGGAGGGTTCGAAGGGGGAGGAGGAGGCAGAGGGCTCCTT
CCCCTGCCC 3′ and 5′ CAGGGAGGCCTTGCTGTCCTG 3′. The two amplicons were
purified on a 1% agarose gel. Ten ng of each was mixed and used as template for a third
PCR amplification using primers 5′ CGAGAATTCTGAGCCATGGATGC 3′ and 5′
CAGGGAGGCCTTGCTGTCCTG 3′. This created a mutated EcoR1-StuI fragment that
was used to replace the WT EcoR1-StuI fragment in pCI-Trim17 to give pCI-Trim17(K2R).
GFP was fused to the C-terminus of Trim17 in pCI by recombinant PCR. A Trim17
fragment with an EGFP overhang, and an EGFP fragment with a Trim17 overhang were
amplified by PCR using pCI-Trim17 and pEGFP (Clontech) as templates and primer pairs 5′
CGAGAATTCTGAGCCATGGATGC 3′/5′
GCCCTTGCTCACGGATCCTCCCTTCACCCACATGGTCACTG 3′ and 5′
CAGTGACCATGTGGGTGAAGGGAGGATCCGTGAGCAAGGGC 3′/5′
AAATCTAGACTATTACTTGTACAGCTCGTCCATG 3′ respectively. The two amplicons
were purified on a 1% agarose gel. Ten ng of each was mixed and used as template for a
third PCR amplification using primers 5′ CGAGAATTCTGAGCCATGGATGC 3′ and 5′
AAATCTAGACTATTACTTGTACAGCTCGTCCATG 3′. The resulting EcoR1-XbaI
fragment was cloned into pCI, to create pCI-Trim17-GFP. pCI-Trim17(C16A)-GFP, pCI-
Trim17(ΔRING)-GFP and pCI-Trim17(K2R)-GFP were created by substituting the EcoR1-
StuI fragment of pCI-Trim17-GFP with those of the respective pCI-Trim17 mutants. The
ShRNA-resistant Trim17 mutant was obtained by recombinant PCR. Two overlapping
fragments were amplified using pCI-Trim17 as template, the first with primers 5′
CGAGAATTCTGAGCCATGGATGC 3′ and 5′
CAATGTACTGTTTGGAAGTAGGGACAGCTGTTTTTTCC 3′ , the second with primers
5′ CTACTTCCAAACAGTACATTGGTCACTCTCACAGAGCC 3′ and 5′
GACTCTAGACTATCCCTTCACCCACATGG3 ′. The two amplicons were purified on a
1% agarose gel. Ten ng of each were mixed and used as template for a third PCR
amplification using primers 5′ CGAGAATTCTGAGCCATGGATGC 3′ and 5′
GACTCTAGACTATCCCTTCACCCACATGG 3′. The resulting amplicon, in which the
ShRNA target site was mutated from 5′ ctgttacccaattccactcta 3′ to 5′ ctacttccaaacagtacattg 3′
(same amino acids encoded by different codons), was cloned between the EcoR1 and XbaI
sites of pCI, to create pCI-Trim17-res. pCI-Trim17-res-mCherry was created by
recombinant PCR. Two overlapping fragments were amplified, the first using pCI-Trim17-
res as template, with primers 5′ CGAGAATTCTGAGCCATGGATGC 3′ and 5′
CTCCTCGCCCTTGCTCACTCCCTTCACCCACATGG 3′. The second PCR used
pmCherry-C2 (Clontech) as template and primers 5′
CCATGTGGGTGAAGGGAGTGAGCAAGGGCGAGGAG 3′ and 5′
ATATCTAGATTACTTGTACAGCTCGTCCATG 3′. The two amplicons were purified on
a 1% agarose gel. Ten ng of each were mixed and used as template for a third PCR
amplification using primers 5′ CGAGAATTCTGAGCCATGGATGC 3′ and 5′
ATATCTAGATTACTTGTACAGCTCGTCCATG 3′. The resulting amplicon was cloned
between the EcoR1 and XbaI sites of pCI, to create pCI-Trim17-res-mCherry. The
sequences of all the constructs of Trim17 were confirmed by sequencing.
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tProduction of GST-Trim17 recombinant proteins and in vitro ubiquitination assay
In order to produce recombinant GST-Trim17 fusion proteins in Escherichia coli, an N-
terminal GST tagged Trim17 was produced by PCR amplification of the Trim17 coding
region using pCI-Trim17 or the different pCI-Trim17 mutants as templates and primers 5′
CGAGAATTCGATGCGGTGGAGC 3′ and 5′ CGACTCGAGCTATCCCTTCACC 3′. The
PCR products were cloned between the EcoRI and XhoI sites of the pGEX4T1 vector
(Amersham). The resulting pGEX-Trim17 and pGEX-Trim17 mutants were transformed in
BL21 codon plus (DE3) RP Escherichia coli. Protein expression was induced by the
addition of 200 μM IPTG and was carried out at 20°C for 4 h in the presence of 100 μM
ZnCl2 and 200 μM MgSO4. Bacteria were harvested by centrifugation and resuspended in
TNGN buffer (50 mM Tris-HCl pH = 7.5, 100 mM NaCl, 10% glycerol, 1% NP-40, 100 μM
ZnCl2, 200 μM MgSO4) supplemented with fresh DTT 1 mM and protease inhibitor cocktail
(complete EDTA-free, Roche). Bacterial suspensions were incubated for 30 min at 4°C with
1 mg/ml lysozyme (Fluka) and lysed by sonication. The soluble protein fraction was
recovered by centrifugation. GST fusion proteins were isolated by binding to glutathione
magnetic beads (MagneGST™ Glutathione Particles, Promega) pre-equilibrated with PBS.
The soluble protein fraction was allowed to bind to the beads for 30 min at room
temperature on a rotating wheel before washing the beads three times with 0.65 M NaCl and
three times with PBS. In vitro ubiquitination reactions were carried out by adding 50 ng of
human recombinant His-tagged ubiquitin-activating enzyme E1 (from BostonBiochem
#E-304), 500 ng human recombinant His-tagged ubiquitin-conjugating enzyme (E2) Ube2e1
(from BIOMOL International) or purified Ube2d2 or Ube2d3, and 10 μg of ubiquitin
(Sigma) to ≈1 μg of recombinant GST-Trim17 still bound to the beads in 20 μl of
ubiquitination assay buffer (50 mM Tris-HCl pH = 7.5, 50 mM NaCl, 4 mM ATP, 4 mM
MgCl2, 2 mM DTT, 10 mM phosphocreatine, 0.5 U creatine kinase, 20 μM ZnCl2. When
indicated, the E2 was replaced by 1 μl of wheat germ extract (Promega). Reactions were
incubated at 37°C for 2 h under gentle shaking, and then stopped by adding 10 μl of 2 ×
SDS-PAGE loading buffer and heating at 95°C for 5 min. The samples were immediately
resolved by SDS-PAGE and blotted for ubiquitinated protein products using the non purified
antibody against full-length Trim17. Membranes were subsequently stripped and reprobed
with a rabbit polyclonal anti-ubiquitin antibody (Dako #Z0458).
Transfection of CGN
CGN grown on glass coverslips in 24-well plates were transfected at DIV 6 with pCI
expression vectors encoding GFP (as a control) or different forms of Trim17 fused to GFP.
For this purpose, we used a calcium phosphate protocol that has been optimized for neuronal
cultures by the group of Dr M.E. Greenberg,39 with slight modifications. Briefly, the
conditioned culture medium was removed, filtered and saved. The neurons were washed
twice and incubated for 1 h with DMEM (Dulbecco’s modified Eagle’s medium)
supplemented with 25 mM KCl, 1 μM (+)-MK-801, 10 mM MgCl2 and 5 mM HEPES, pH
= 7.5. During this time, the DNA/calcium phosphate precipitate was prepared by mixing one
volume of DNA in 250 mM CaCl2 with an equal volume of 2 × HBS (274 mM NaCl, 10
mM KCl, 1.4 mM Na2HPO4, 15 mM D-glucose, 42 mM HEPES, pH 7.0). Two μg of
plasmid DNA in 30 μl of CaCl2, mixed with 30 μl 2 × HBS, was used per well. The
precipitate was allowed to form for 30 min at room temperature. Then, 60 μl of the DNA/
calcium phosphate precipitate were added drop-wise to each well and cultures were returned
to the CO2 incubator for 50 to 60 min. The incubation was stopped by “shocking” neurons
for 1 min with 1 × HBS supplemented with 10 mM MgCl2, 2% DMSO and 5 mM HEPES,
pH = 7.5. CGN were then washed twice with DMEM supplemented with 25 mM KCl and 1
μM (+)-MK-801. The saved conditioned medium was added back to each well and the
cultures were returned to the 5% CO2 incubator at 37°C. This protocol allows a transfection
efficiency of up to 15% with minimal toxicity. Sixteen h after transfection, CGN were
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tincubated in K5 medium for 8 h or left untreated. CGN were fixed, stained with Hoechst
33258 and analyzed by immunofluorescence in some experiments. Coverslips were mounted
on glass slides in Mowiol and transfected neurons were detected by GFP fluorescence.
Among GFP-positive neurons, apoptosis was assessed by observing the morphology of the
cell and detection of nuclear condensation or fragmentation by Hoechst staining. For each
experiment and each condition, at least 200 GFP-positive neurons were scored in a blinded
manner. Statistical analyses were performed using GraphPad InStat version 3.0 for Mac
(GraphPad Software, San Diego California USA, www.graphpad.com).
Microinjection of SCG sympathetic neurons
SCG sympathetic neurons were microinjected with expression vectors (50 ng/μl) together
with 5 μg/μl Texas Red dextran Mr = 70 000 (Molecular Probes) as a marker in 0.5 × PBS
(− Ca2+; − Mg2+) as described previously.31 A few hours after injection, the neurons were
rinsed twice with fresh SCG medium lacking NGF and further cultured with fresh SCG
medium containing NGF (+ NGF) or anti-NGF antibody (− NGF). The injected cells were
then counted using an inverted fluorescence microscope and the number of viable,
morphologically normal injected (Texas Red positive) neurons at this time (0 h) was set to
100% in each case. Viable injected SCG neurons were recounted 24, 48, 72 and 96 h after
NGF withdrawal in a blinded manner. Three independent experiments were performed with
120–140 neurons injected per injection mix.
Trim17 siRNAs, or non-targeting control siRNA, were microinjected as described
previously.40 3 μM of the individual siRNA were microinjected into the nucleus together
with 2.5 μg/μl of purified guinea-pig IgG (Jackson Immunoresearch Inc.) as a marker.
Microinjected cells were returned to culture for 24 h to allow the pre-existing Trim17
protein to degrade. Then, neurons were deprived of NGF for 16 h, fixed and stained for
immunofluorescence analysis. Alternatively, neurons were microinjected with siRNAs
together with a fluorescent marker, cultured for 24 h and deprived of NGF for increasing
times. Viability was assessed as described above. Non-targeting control siRNA
oligonucleotides (Dharmacon accession number D-001810-03-05) were purchased from
Dharmacon. The sequences targeted by the Trim17 siRNAs used were the following:
Trim17#1 5′ UGUUUCUGGUGGAAGAAGA 3′; Trim17#2 5′
ACUGGGAAGUGGGCAUGAA 3′.
Lentivirus preparation and lentiviral transduction of CGN
The HIV-derived lentiviral vectors pLKO.1 containing the ShRNAs TRCN0000037335
(ShRNA control) and TRCN0000037337 (ShRNA Trim17) were obtained from Open
Biosystems. They both target specific sequences in Trim17 mRNA but TRCN0000037335
appeared to be inefficient in reducing the level of endogenous Trim17 protein and was thus
used as a negative control. Lentiviruses were produced as described.41 Briefly, Lenti-X 293
T cells (Clontech) were transfected with pLKO.1 derived constructs together with the
pCMVΔR8.91 and phCMV-G (expressing the vesicular stomatitis G envelope) packaging
plasmids at a 3:3:1 ratio using calcium phosphate precipitation. One day after transfection,
the initial culture medium was replaced by a small volume of serum-free medium for 24-30
h. The conditioned medium was harvested, passed through a 0.45 μm pore filter and
concentrated by ultracentrifugation using an SW28 rotor (Beckman) at 80 000 × g for 2 h at
4 °C. The lentiviruses were resuspended in serum-free medium and titrated using a p24
ELISA kit (Innotest® from Innogenetics) according to the instructions of the manufacturer.
Lentiviral preparations were kept frozen in small aliquots at −80 °C until use. CGN were
transduced one day after plating, in the absence of Ara-C. Approximately 500 ng p24 of
each lentiviral preparation were added, per million neurons, directly to the culture medium
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t(in a reduced volume) for 8 h. Neurons were then replaced in fresh medium and culture was
continued until 6 DIV.
Western blot analysis
Following transduction with lentiviruses expressing different ShRNAs for 5 days and KCl
deprivation for 7 h, CGN were harvested in lysis buffer (50 mM Tris-HCl [pH 7.5], 250 mM
NaCl, 0.1% Triton-X100, 1 mM DTT, 5 mM iodoacetamide, 20 μM MG-132 and protease
inhibitor cocktail [Sigma]) and homogenized by thorough vortexing. Cell debris were
removed by centrifugation at 500 × g for 5 min at 4°C, and the protein concentration of the
resulting supernatant was estimated using the Bradford reagent (Sigma) with BSA as the
standard. Aliquots (15 μg) of supernatant protein were diluted in sample buffer, boiled for 5
min, separated by 15% SDS-PAGE and finally transferred to Hybond™-P (GE Healthcare)
PVDF membrane. After blocking non-specific sites for 1 h at room temperature with 5%
non-fat milk in Tris-buffered saline (TBS) supplemented with 0.1% Tween-20, the
membrane was incubated overnight at 4°C with primary antibodies diluted in TBS-Tween
supplemented with 2.5% milk: anti-cleaved caspase 3 (1:1000) and polyclonal anti-caspase
3 (Stressgen #AAP-103; 1:500). After washing the membranes three times in TBS-Tween,
the blots were incubated with the anti-rabbit horse radish peroxidase-linked goat secondary
antibody (Jackson ImmunoResearch Laboratories Inc.) diluted in TBS-Tween supplemented
with 2.5% milk for 1 h at room temperature and subsequently washed three times in TBS-
Tween. The immunoreactive proteins were visualized using enhanced chemiluminescent
substrate (Pierce). To confirm equal loading and transfer, the membrane was subsequently
stripped and reprobed for actin (Chemicon International, mouse monoclonal antibody
#MAB1501R; 1:2000).
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Abbreviations
UPS ubiquitin-proteasome system
CGN cerebellar granule neurons
[KCl]o extracellular concentration of KCl
K25 serum-free medium containing 25 mM KCl
K5 serum-free medium containing 5 mM KCl
PI3K Phosphatidyl Inositol-3-OH Kinase
GSK3 Glycogen Synthase Kinase 3
SCG superior cervical ganglion
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tNGF nerve-growth factor
EGL external granular layer
ML molecular layer
IGL internal granular layer
P days after birth (post-natal)
E days of embryonic development
DIV days in vitro
WT wild type
GFP green-fluorescent protein
ShRNA short hairpin RNA
siRNA small interfering RNA
BSA bovine serum albumin
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tFigure 1. Trim17 mRNA is highly increased during transcription-dependent CGN apoptosis
a: CGN cultures were left untreated (control: time 0) or washed and switched to serum free
medium containing either 25 mM KCl (K25) or 5 mM KCl (K5) for indicated times. Total
RNA was extracted and mRNA content for Trim17 was estimated by quantitative RT-PCR.
Fold change was calculated by comparison with neurons maintained in initial culture
medium (control). Data are means ± SD of triplicate determinations and are representative
of seven independent experiments. b: CGN were left untreated or incubated for 4 h in K25
medium in the absence or the presence of 40 μM LY294002 (LY, PI3K inhibitor) or in K5
medium in the absence or the presence of 10 μM AR-A014418 (AR, GSK3 inhibitor). Then
mRNA content for Trim17 was estimated under each condition in comparison with control
neurons. Data are means ± SD from three independent experiments. c-e: CGN were
incubated with different drugs for 24 h and neuronal survival was estimated by an MTT
assay. Results are expressed as percentage survival with respect to cultures maintained in
K25 medium without drugs. Data are means ± SD of triplicate determinations and are
representative of three independent experiments. c: CGN were incubated in K25, K5 or K25
medium supplemented with 40 μM LY294002 (LY), in the absence or presence of 1 μg/ml
actinomycin D (ActD, transcription inhibitor). d: CGN were incubated in K25 or K5
medium in the absence or presence of 10 μM AR-A014418 (AR). e: CGN were incubated in
K25 medium in the absence or presence of 30 μM glutamate (Glu), in the absence or
presence of 1 μg/ml actinomycin D.
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tFigure 2. Induction of the Trim17 protein during in vitro neuronal apoptosis
a: Detection of endogenous Trim17 by confocal immunofluorescence using an anti-peptide
antibody against Trim17 in primary CGN incubated for 8 h in K25 or K5 medium. The
lower pictures show nuclear staining with Hoechst 33258 in the same fields. Note that the
most intense Trim17 signals are detected in neurons committed to death but not in neurons
already undergoing apoptosis. b: Detection of endogenous Trim17 by fluorescence
microscopy using the same antibody as in a in primary SCG neurons incubated for 16 h in
the presence or the absence of NGF. The lower pictures show nuclear staining with DAPI in
the same fields.
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tFigure 3. Expression of the Trim17 protein during developmental neuronal apoptosis
a: Trim17 and active caspase 3-immunolabelled sagittal cerebellar sections of a post-natal
day 7 (P7) mouse. EGL: external granular layer; ML: molecular layer; IGL: internal
granular layer. Arrows indicate positive neurons. b: Sagittal cerebellar sections of mice from
different stages of post-natal development were analyzed by immunohistochemistry. The
numbers of CGN that were immunopositive for active caspase 3 on one hand, and for
Trim17 on the other hand, were estimated and represented per mm2 of cerebellum section
using two different scales. c: Two adjacent sections (4 μm) of cerebellum from a P7 mouse
were immunolabelled with antibodies against Trim17 and active caspase 3 respectively.
Note the co-localization of the two stainings indicated by an arrow and * (also present in a).
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tFigure 4. E3 ubiquitin-ligase activity of Trim17 and its mutants
a: Purified recombinant GST-Trim17(WT) was incubated for 2 h in the presence of all in
vitro ubiquitination assay components with the exception of ubiquitin and E2 enzyme (first
lane), in the presence of ubiquitin and different E2 enzymes (Ube2e1, Ube2d2 and Ube2d3)
as indicated. b: Schematic representation of the WT mouse Trim17 protein and its mutant
ΔRING (upper part). Diagram of the RING domain of WT Trim17 and two point mutants of
the RING domain: C16A and K2R (lower part). The conserved Cys and His that coordinate
two atoms of zinc are represented, as well as the 8 Lys present in the RING. Five of these 8
Lys, that are all gathered within a stretch of 12 residues, are conserved between mouse, rat
and human, the three others being replaced by Arg in human. c: In vitro ubiquitination
assays were performed using GST-Trim17(WT) and GST-Trim17 mutant proteins (K2R,
ΔRING and C16A), in the presence of all of the assay components including Ube2d3 as an
E2 enzyme, except in the first lane in which all of the assay components were incubated in
the absence of recombinant Trim17 and in the second lane in which GST-Trim17(WT) was
incubated in the presence of all assay components but in the absence of ubiquitin. a & c:
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full-length Trim17. The membranes were subsequently stripped and reprobed for ubiquitin.
The arrows indicate GST-Trim17 and GST-Trim17(ΔRING). The mono-ubiquitinated form
of Trim17 is indicated by **. Higher bands are poly- or multi-ubiquitinated forms of
Trim17.
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tFigure 5. Overexpression of Trim17 induces the intrinsic apoptotic pathway in CGN
CGN were transfected with GFP (a), Trim17-GFP (b) or Trim17(ΔRING)-GFP (c) for 25 h.
Then, neurons were fixed and immunostained for cytochrome c or for the active form of
caspase 3. Transfected neurons were detected by GFP fluorescence and nuclei were
visualized by Hoechst 33258 staining. Thick arrows indicate Trim17-expressing neurons
that undergo apoptosis, whereas thin arrows indicate healthy neurons expressing GFP,
Trim17-GFP or Trim17(ΔRING)-GFP. In healthy neurons, cytochrome c immunostaining is
intense and punctate, indicating a mitochondrial localization. In apoptotic neurons, no
staining is visible because cytochrome c is rapidly degraded after release from mitochondria.
The shape of GFP-positive neurons was drawn on the cytochrome c picture to facilitate
interpretation of the image.
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tFigure 6. Trim17-induced neuronal apoptosis is Bax-dependent
a: CGN from WT and Bax-deficient mouse littermates were transfected with Trim17-GFP
for 25 h and fixed. Trim17 was detected by GFP fluorescence and nuclei were visualized by
Hoechst 33258 staining. Note that the morphology of the nucleus and of the cell body is
normal in Bax−/− neurons transfected with Trim17-GFP, whereas the cytoplasm is shrunken
and the chromatin condensed or fragmented in a large proportion of Bax+/+ neurons
expressing Trim17-GFP (indicated by thick arrows). b: CGN from Bax−/−, Bax+/− and
Bax+/+ mouse littermates were transfected with GFP (control) or with the active forms of
Trim17 (WT and K2R) fused to GFP for 25 h. The percentage of apoptosis among
transfected neurons was assessed by examining cell morphology and nuclear condensation
of GFP-positive neurons. Data are representative of three independent experiments.
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tFigure 7. The E3 activity of Trim17 is necessary for neuronal apoptosis
a: CGN were transfected with GFP (as a negative control) or with different mutants of
Trim17 fused to GFP for 16 h and were left untreated (Ctrl) or were incubated in K5
medium for 8 h. Then, CGN were fixed and stained with Hoechst 33258. Among GFP-
positive neurons, the percentage of apoptosis was assessed by observing cell morphology
and nuclear condensation. Data are the mean ± SD of three independent experiments. *
p<0,001 significantly different from the corresponding GFP control (ANOVA followed by
Bonferroni multiple comparisons test). b: CGN were transfected with Trim17(ΔRING)-GFP
for 16 h and were incubated in K5 medium for 8 h. Then, neurons were fixed and
immunostained for cytochrome c or for the active form of caspase 3. CGN expressing
Trim17(ΔRING)-GFP were detected by GFP fluorescence and nuclei were visualized by
Hoechst 33258 staining. Arrows indicate neurons expressing Trim17(ΔRING)-GFP. In these
neurons, immunostaining for cytochrome c is intense and punctate indicating that it has not
been released from mitochondria. In contrast cytochrome c immunostaining is diffuse and
fainter in surrounding dying neurons. The shape of GFP-positive neurons was drawn on the
cytochrome c picture to facilitate interpretation of the image. c: SCG neurons were
microinjected with the empty vector pCI or plasmids expressing the different forms of
Trim17 together with a fluorescent marker. Then, neurons were further cultured in medium
containing NGF (+ NGF, only for empty pCI) or lacking NGF (− NGF, for all constructs).
Viability of injected SCG neurons was assessed at this time (time 0, 100% survival) and
subsequently, every 24 h. Data are the mean ± SD of three independent experiments. *
p<0,001 significantly different from the value obtained with pCI – NGF at the same time
(ANOVA followed by Bonferroni multiple comparisons test).
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tFigure 8. Expression of Trim17 is necessary for neuronal apoptosis
a: CGN plated on glass coverslips in 24 well plates were not treated (non transduced) or
were transduced with lentiviral particles expressing ShRNA sequences (control and Trim17)
one day after plating. At DIV 6, neurons were incubated for 8 h in K5 medium. Then,
neurons were fixed, immunostained for endogenous Trim17 using the affinity purified anti-
peptide antibody and stained with DAPI to reveal nuclear morphology. The data are
representative of two independent experiments. b: CGN were treated as in a and the
percentage of apoptotic neurons displaying condensed nuclei was estimated in six random
fields per condition (approximately 800 cells counted in total per condition). Data are the
mean ± SD of four independent experiments. * p<0,01 significantly different from non-
transduced neurons in the same condition (ANOVA followed by Bonferroni multiple
comparisons test). c: CGN plated in six well plates were not treated (non transduced) or
were transduced with lentiviral particles expressing ShRNA sequences (control and Trim17)
one day after plating. At DIV 6, neurons were incubated for 7 h in K5 medium or
maintained in the initial culture medium (ctrl). Then, proteins were extracted and analyzed
by Western blot using antibodies against caspase 3 and actin. d: SCG neurons were
microinjected with 3 μM siRNA: non-targeting control (NTC), and siRNAs targeting two
different sequences in Trim17 mRNA (Trim17 siRNA#1 and Trim17 siRNA#2) together
with guinea pig IgG. After 24 h, neurons were deprived of NGF for 16 h and were fixed.
Endogenous Trim17 was detected with the same antibody as in a, microinjected neurons
were visualized with fluorescent anti-guinea pig secondary antibody and nuclei were stained
with DAPI. The data are representative of three independent experiments. The shape of
microinjected neurons was drawn on the Trim17 picture to facilitate interpretation of the
image. e: SCG neurons were microinjected with the same siRNAs as in d, together with a
fluorescent marker. The plasmid expressing Trim17 (pCI-Trim17, 50 ng/μl) was also
microinjected as a control to assess the levels of neuronal death in the presence and the
absence of NFG. Twenty four hours after microinjection, neurons were further cultured in
medium containing NGF (+ NGF, only for pCI-Trim17) or lacking NGF (− NGF, for all
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tother conditions) for 72 h. Viability of injected SCG neurons was then assessed and
expressed as percentage of the survival determined at the time of NGF deprivation. Data are
the mean ± SD of six independent experiments. * p<0,01 significantly different from the
value obtained in neurons injected with NTC siRNA (ANOVA followed by Dunnett
multiple comparisons test).
Lassot et al. Page 27
Cell Death Differ. Author manuscript; available in PMC 2011 June 1.
U
K
P
M
C
 
F
u
n
d
e
r
s
 
G
r
o
u
p
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
U
K
P
M
C
 
F
u
n
d
e
r
s
 
G
r
o
u
p
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tFigure 9. Transfection of a ShRNA resistant Trim17 construct restores KCl deprivation-induced
apoptosis in transduced CGN
One day after plating, CGN were transduced with lentiviral particles expressing the ShRNA
sequence directed against Trim17 mRNA that efficiently decreases the level of endogenous
Trim17 (ShRNA Trim17). At DIV 5, neurons were transfected with pmCherry-C2 or with
pCI-Trim17-res-mCherry (in which the sequence targeted by the ShRNA Trim17 is
mutated). At DIV 6, CGN were incubated for 8 h in K5 medium. Then, neurons were fixed,
CGN expressing mCherry or Trim17-res-mCherry were detected by mCherry fluorescence
and nuclei were visualized by Hoechst 33258 staining. The data are representative of two
independent experiments.
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Table 1
Increase of Trim17 mRNA in different transcription-dependent and -independent models of neuronal apoptosis
SCG neurons ± NGF Motoneurons
± trophic factors
CGN
± glutamate
Trim17 mRNA ratio 3.45 ± 1.17 2.56 ± 0.82 0.66 ± 0.06
c-jun mRNA ratio 4.95 ± 3.33 2.22 ± 0.91 0.81 ± 0.06
Primary cultures of rat sympathetic SCG neurons were grown for 16 h in the presence or the absence of NGF. Primary mouse motoneurons were
cultured for 24 h in the presence or the absence of a cocktail of neurotrophic factors. CGN were incubated in K25 medium in the absence or the
presence of 30 μM glutamate for 8 h. Then, total RNA was extracted and mRNA contents for Trim17 and c-jun were estimated by quantitative RT-
PCR. In each condition, the mRNA ratio apoptotic versus survival conditions was calculated. The level of c-jun was used as an index of
transcription-dependent neuronal apoptosis. Data are means ± SD from three independent experiments.
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Table 2
Scoring of endogenous Trim17 depletion in SCG neurons microinjected with siRNAs
high depletion low-medium depletion no depletion
NTC siRNA 1.6 7.2 91.2
Trim17 siRNA#1 77.7 15.7 6.6
Trim17 siRNA#2 30.5 40.6 28.9
SCG neurons were microinjected with 3 μM siRNA: non-targeting control (NTC), and siRNAs targeting two different sequences in Trim17 mRNA
(Trim17 siRNA#1 and Trim17 siRNA#2) together with guinea pig IgG as a marker. Twenty-four hours after microinjection, neurons were deprived
of NGF for 16 h, and were fixed. Endogenous Trim17 was detected using the affinity purified anti-peptide antibody, and microinjected neurons
were visualized with fluorescent anti-guinea pig secondary antibody. Depletion of Trim17 was scored as follows: high depletion in which there was
almost no Trim17 detected in the injected neuron; low-medium depletion in which there was a clear reduction of the protein level but Trim17 was
still expressed; no depletion meaning that the Trim17 staining was similar to non-injected neurons. The data are representative of two independent
experiments (with more than 120 microinjected neurons per condition and per experiment).
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